COVID-19 vaccines versus pediatric hospitalization.

ABSTRACT: Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.

SUBMITTER: Rosa Duque JS 

PROVIDER: S-EPMC9868379 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature